ADVERTISEMENT

Prostate cancer: androgen deprivation therapy increases diabetes risk

Deepa Koli   |   Clinical Summary   |   02 January 2023
ADVERTISEMENT

Takeaway

  • Androgen deprivation therapy (ADT) is associated with increased risk for diabetes but not for metabolic syndrome in patients with prostate cancer.

Why this matters

  • Findings support the National Comprehensive Cancer Network guideline recommendations that ADT should not be initiated in patients with localized prostate cancer since it does not...

          

Topic Challenges

left
right